Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 15 06:28 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 15 06:19 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 10 06:57 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 19 06:36 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 6 06:03 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 6 06:03 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 21 06:05 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 12 00:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 5 00:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 4 00:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 4 00:00 ET
Innate Pharma | F-3: Registration statement for specified transactions by certain foreign private issuers
Dec 20, 2023 16:45 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 20, 2023 16:30 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 19, 2023 06:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 18, 2023 11:40 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 11, 2023 06:01 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 11, 2023 06:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 27, 2023 06:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 7, 2023 06:01 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 3, 2023 06:00 ET
No Data
No Data